Etude de marché - Industrie pharmaceutique

Mon compte | Mon panier (0) | Contactez-nous | Abonnez-vous !

Résultats 491 - 500 de 2,843 sur 52 éditeurs


Industrie pharmaceutique
Vitamines - Compléments alimentaires (19) Antalgiques (10) Maladies cardiovasculaires (150) Maladies digestives (27) Maladies infectieuses (21)	Neurologie (17) Oncologie (21) Médicaments en vente libre (85) Maladies respiratoires (48)

RSS_US

RSS_FR

Stakeholder Opinions: Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success?
Datamonitor \| 174 pages \| Décembre 2007 \| Anglais
IntroductionNon-Hodgkin's lymphoma (NHL) is the most common hematological malignancy and is comprised of around 30 different disease subtypes. Each of these present with a distinct set histological ...	3.040,00 €

03-018: Market Opportunities in Cytokine & Growth Factor Research
BioInformatics \| 170 pages \| Mai 2003 \| Anglais
This report identifies preferred quantification and activity assays, new research trends and the most popular suppliers of antibodies, recombinant proteins and DNA microarrays ...	800,00 €

Premium Company Profile: Depomed
Datamonitor \| 51 pages \| Novembre 2007 \| Anglais
IntroductionDepomed is a specialty pharmaceutical company engaged in the development and commercialization of products that are based on its oral drug delivery technologies. Depomed's business stra ...	396,00 €

Indian Pharmaceutical Industry
TriMark \| 183 pages \| Octobre 2005 \| Anglais
The purpose of this study is to describe the specific segment of the pharmaceutical market sector called the Indian pharmaceutical industry. This sector includes all of the generally accepted pharm ...	800,00 €

Disease and Therapy Review: Stroke
Timely Data Resources \| 7 pages \| Septembre 2006 \| Anglais
The Stroke Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatments. General information is provided on the ...	720,00 €

Innovation in Natural and Organic Food and Drinks: Winning NPD strategies and future trends in healthy and ethical products
Datamonitor \| 122 pages \| Mai 2006 \| Anglais
The terms natural and organic are not mutually exclusive: many products are marketed as ‘natural’ without organic certification; likewise, a number of organic products do not incorporate the term ‘nat ...	1.528,00 €

Pipeline Insight: Asthma/COPD - Targeted therapies on the horizon
Datamonitor \| 214 pages \| Novembre 2006 \| Anglais
IntroductionThe total asthma and COPD population in 2006 is estimated to be 44.8 million and 28.8 million respectively. While the majority of patients are well controlled with current therapies, th ...	9.690,00 €

Dialysis Patients in Asia, 1999-2003
TriMark \| 1 page \| Janvier 2006 \| Anglais
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...	80,00 €

Stakeholder Opinions: Hepatocellular Carcinoma - Opportune indication for novel therapies
Datamonitor \| 114 pages \| Juin 2007 \| Anglais
IntroductionThe close association with hepatitis means that hepatocellular carcinoma (HCC) is common in developing countries where hepatitis B and C infections are endemic. However, the increasing ...	3.040,00 €

MarketWatch: Cancer
Datamonitor \| 34 pages \| Mai 2006 \| Anglais
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the ...	160,00 €

1	\|	2	\|	3	\|	4	\|	5	\|	6	\|	7	\|	8	\|	9	\|	10	\|	11	\|	12	\|	13	\|	14	\|	15	\|	16	\|	17	\|	18	\|	19	\|	20	\|	21	\|	22	\|	23	\|	24	\|	25	\|
26	\|	27	\|	28	\|	29	\|	30	\|	31	\|	32	\|	33	\|	34	\|	35	\|	36	\|	37	\|	38	\|	39	\|	40	\|	41	\|	42	\|	43	\|	44	\|	45	\|	46	\|	47	\|	48	\|	49	\|	50	\|	51	\|	52	\|	53	\|	54	\|	55	\|	56	\|	57	\|	58	\|	59	\|	60	\|	61	\|	62	\|	63	\|	64	\|	65	\|	66	\|	67	\|	68	\|	69	\|	70	\|	71	\|	72	\|	73	\|	74	\|	75	\|
76	\|	77	\|	78	\|	79	\|	80	\|	81	\|	82	\|	83	\|	84	\|	85	\|	86	\|	87	\|	88	\|	89	\|	90	\|	91	\|	92	\|	93	\|	94	\|	95	\|	96	\|	97	\|	98	\|	99	\|	100	\|
>>

CIPLS